Anna van der Breggen and Chantal Blaak to retire in 2021 and 2022
May 10 2020 10:31 pm CET

Anna van der Breggen and Chantal Blaak to retire in 2021 and 2022
Anna van der Breggen and Chantal Blaak to retire in 2021 and 2022
Boels Dolmans Cycling Team

Boels-Dolmans' Anna van der Breggen and Chantal Blaak have announced that they are set to retire in 2021 and 2022, respectively.

The 30-year-old riders feel that their moment as professional cyclists is almost over, but they will remain in the sport after that. For Van Der Breggen -who won a Gold Medal in Rio de Janeiro 2016, was World Champion and has taken victories in races like the Tour of Flanders, Liege-Bastogne-Liege and the Giro Rosa- retirement will come after the Olympic Games of Tokyo.

"I signed for one more year as a cyclist," said the rider to Dutch broadcaster NOS. "After that, I stay at the team but as a sports director. So I will stop cycling after next year.

"I notice that I really feel motivation for the Olympic Games, but that feeling is less for all the other competitions. And I think as a top athlete you really need to have that motivation, a feel from very deep within: I want to win."

For Blaak -who was World Champion in 2017 and has won races like the Amstel Gold Race and Gent-Wevelgem- the end of her career will be after the classics of 2022. "I also signed a contract but for one year and a half," explained the Dutch rider. "And that will be the end of my career.

"I really want to stop at the highest level, so when do you stop? That is a difficult choice but I think this is a very nice moment."

Blaak will also remain in the team -which will be named SD Worx from next season- as a sports director. "With the men is quite normal for ex-riders to become sports directors, but with the women it is a hand shake and a 'see you soon'," affirmed the current director of Boels-Dolmans Danny Stam. "I think we are quite trendsetters by including our icons as directors for the team."
SUBSCRIBE TO RSS FEEDS

ANNA VAN DER BREGGEN
CHANTAL BLAAK





COMMENTS